Centiva Capital’s Lydall, Inc. LDL Stock Holding History

Centiva Capital’s Portfolio LDL Stock Details LDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,259	Closed	-$924K	–	1784
2021 Q2	$924K	Buy	+15,259	New	+$587K	0.02%	607

Other funds holding LDL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Centiva Capital's LDL Position: Q3 2021 in Review

Centiva Capital sold out of Lydall, Inc. (LDL) in Q3 2021, closing a stake of 15,259 shares — an estimated $924K sold.

Centiva Capital first reported a position in LDL in Q2 2021 and held it in 1 quarter. The position peaked at $924K in Q2 2021. 158 funds tracked by Wall St. Rank hold LDL as of Q3 2021.

Centiva Capital reported no remaining Lydall, Inc. position as of Q3 2021 after selling out during the quarter.
Centiva Capital sold 15,259 Lydall, Inc. shares in Q3 2021, an estimated $924K.
Centiva Capital first reported a position in Lydall, Inc. in Q2 2021 and held it in 1 quarter.
Centiva Capital's Lydall, Inc. position peaked at $924K in Q2 2021.
158 funds tracked by Wall St. Rank held Lydall, Inc. as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.